20101 results for «»

Filter By

20101 results

AICT-AsiaPCR 2025 Opening ceremony

10 Oct 2025 – From AICT-AsiaPCR 2025

The AICT-AsiaPCR 2025 Opening Ceremony marked the commencement of the conference's comprehensive program, setting the stage for cutting-edge discussions and advancements in interventional cardiology across the Asia-Pacific region.

AICT-AsiaPCR 2025 Opening ceremony

Abdulhameed Alfaddag

TRIGISTRY: Advancing real-world understanding of tricuspid valve disease

07 Nov 2025

Edoardo Zancanaro interviews Julien Dreyfus and David Messika-Zeitoun about TRIGISTRY, an international registry that builds on the TRI-SCORE — now part of the 2025 ESC guidelines. The study confirms that early referral and optimal reduction of tricuspid regurgitation are key to improving outcomes. The team now...

TRIGISTRY insights

Randomised comparison of intravascular lithotripsy vs. cutting balloon treatment in calcified coronary artery disease – The Short-CUT trial

27 Oct 2025

Aaysha Cader provides her take on the Short-CUT trial presented by Suzanne J. Baron at TCT 2025, in San Francisco.

Author

Aaysha Cader
Randomised comparison of intravascular lithotripsy vs. cutting balloon treatment in calcified coronary artery disease – The Short-CUT trial

A randomised, multicenter, non-inferiority comparison of intravascular lithotripsy and super-high-pressure non-compliant balloons for treatment of calcified and refractory coronary lesions - The VICTORY trial

27 Oct 2025

Mirvat Alasnag provides her take on the VICTORY trial presented by Matthias Bossard at TCT 2025 in San Francisco.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
VICTORY: Intravascular lithotripsy vs. super-high-pressure PTCA in calcified and refractory coronary lesions

Percutaneous transseptal transcatheter mitral valve replacement using a dedicated balloon-expandable valve: 1-year outcomes from the ENCIRCLE trial using the SAPIEN M3

27 Oct 2025

Jonathan Curio provides his take on the ENCIRCLE Trial presented by David Daniels at TCT 2025 in San Francisco.

Jonathan Curio

Author

Jonathan Curio
Percutaneous transseptal transcatheter mitral valve replacement using a dedicated balloon expandable valve: 1 year outcomes from the ENCIRCLE trial using the SAPIEN M3

Comparison of drug-coated versus conventional balloons for treatment of side branches of bifurcation lesions: the OCVC-BIF study

29 Oct 2025

Ali Nazmi Calik provides his take on the OCVC-BIF study presented by Takayuki Ishihara at TCT 2025, in San Francisco.

Author

Ali Nazmi Calik
Comparison of drug-coated versus conventional balloons for treatment of side branches of bifurcation lesions: The OCVC-BIF study

STRIVE: intracoronary low-dose recombinant tissue plasminogen activator in primary PCI for STEMI and large thrombus burden

25 Oct 2025

Elad Asher provides his take on the STRIVE study presented by Shamir R. Mehta at TCT 2025, in San Francisco.

Elad Asher

Author

Elad Asher
STRIVE: intracoronary low-dose recombinant tissue plasminogen activator in primary PCI for STEMI and large thrombus burden

Enjoy a FREE one-year subscription to EuroIntervention

10 Nov 2025

Are you a PCR Companion participating in PCR London Valves 2025? Activate your one-year print and/or digital subscription to EuroIntervention

Activate your free EuroIntervention subscription

Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial

31 Oct 2025

Nicola Ryan provides her take on the PROMISE trial presented by Rocco Antonio Montone at TCT 2025, in San Francisco.

Nicola Ryan

Author

Nicola Ryan
Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial

Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery (PROCTOR)

03 Nov 2025

Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Trish Singh

Author

Trish Singh
PROCTOR: PCI of native coronary artery vs SVGin patients with prior CABG

Ten trials from AHA 2025

12 Nov 2025

Alessandro Sticchi provides us with a curated overview of the late-breaking trials he found most relevant for interventional cardiologists from AHA 2025.

Alessandro Sticchi

Author

Alessandro Sticchi
Ten trials from AHA 2025

iFR versus angiography-guided CABG: 3-year results of the iCABG randomised trial

31 Oct 2025

Alex Sticchi provides his take on the iCABG trial presented by Rasa Ordiene at TCT 2025, in San Francisco.

Alessandro Sticchi

Author

Alessandro Sticchi
iFR versus angiography-guided CABG: 3-year results of the iCABG randomized trial

PARTNER 3: transcatheter or surgical aortic-valve replacement in low-risk patients at 7 years

14 Nov 2025

At 7 years, low-risk patients affected by severe symptomatic aortic valve stenosis 1:1 randomly treated by SAPIEN 3 TAVI or surgery showed similar clinical outcomes and late valve durability

Igor Belluschi

Reviewer

Igor Belluschi

Reviewer

Salvatore Brugaletta
PARTNER 3: TAVR or SAVR in low-risk patients at 7 years

Lukas Stolz

Munich, Germany

Amar Krishnaswamy

Cleveland, United States of America

The effectiveness and safety of a planned investment procedure in high-risk chronic total occlusions - The INVEST CTO single arm study

03 Nov 2025

Kalaivani Mahadevan and Sofia Papadopoulou provide their take on the INVEST CTO trial, presented by Anja Oksnes at TCT 2025, in San Francisco.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Sofia Papadopoulou

Author

Sofia Papadopoulou
INVEST-CTO: Single arm study of a planned investment procedure in high-risk CTO PCI

Fanglin Lu

Shanghai, China

Frederik Verbrugge

Jette, Belgium

Domenico Giovanni Della Rocca

Brussels, Italy

Didn’t find what you were looking for?